Arturo Araya, Chief Commercial Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 3,000 shares at $3.90 ($12K) on 2019-12-24, disclosed to the SEC on 2019-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.